NCIt definition : The orally available active prodrug of ICRF-154, a bisdioxopiperazine derivative,
with cardioprotective and antineoplastic activities. Like other ICRF compounds, sobuzoxane
and its active metabolite ICRF-154 interfere with topoisomerase II activity prior
to the formation of intermediate cleavable DNA-enzyme complexes during the catalytic
cycle resulting in tumor cell growth inhibition. Furthermore, sobuzoxane chelates
metal cations thereby limiting the formation of free radical-generating anthracycline-metal
complexes and may prevent anthracycline-induced oxidative damage to cardiac and soft
tissues.;
UNII : R1308VH37P;
InChIKey : OCOKWVBYZHBHLU-UHFFFAOYSA-N;
CAS number : 98631-95-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 98631-95-9
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;